Bristol-Myers Squibb (Ireland)

Bristol Myers Squibb (Ireland) is the Irish operation of the global biopharmaceutical company Bristol Myers Squibb. The company describes its mission as discovering, developing and delivering innovative medicines to help patients prevail over serious diseases. Its Irish presence dates to 1964, when Bristol Myers Squibb began operations with an active pharmaceutical ingredient plant in Swords, County Dublin. This date marks the beginning of its Irish operations; the supplied evidence does not establish a separate founding date for an Irish company. The current Irish footprint includes a biologics drug-substance manufacturing facility at Cruiserath in Dublin 15, along with external manufacturing operations in Blanchardstown, Dublin 15, and Shannon, County Clare. The company says Cruiserath is a multi-product cell-culture biologics facility within its global Product Development and Supply network. Its external manufacturing network manages third-party drug manufacturing operations. The Irish site also offers commercial functions and other career opportunities across multiple functions. Bristol Myers Squibb reports employing approximately 1,000 people in Ireland. The Irish website also describes a programme of grants, giving and corporate sponsorship for qualifying non-profit organisations. Potential support includes charitable donations and in-kind support, medical education, scholarships, fellowships, patient education, event sponsorship and broad research grants. Requests are assessed against the company’s business-conduct and ethics principles and applicable Irish pharmaceutical and regulatory requirements. The supplied evidence does not specify Irish product brands, the names of local executives, or a separately incorporated owner; it identifies these activities as part of Bristol Myers Squibb’s wider company network.

Bristol Myers Squibb’s Irish history, as described by the company, begins in 1964. Its first stated Irish operation was an active pharmaceutical ingredient plant in Swords, County Dublin. The evidence establishes the start of operations in Ireland, but does not provide a separate incorporation date for the Irish entity or name the people responsible for establishing the site. Over time, the Irish operation developed beyond that initial API activity. The company’s current account of its footprint identifies a biologics drug-substance manufacturing facility at Cruiserath in Dublin 15 and external manufacturing divisions in Blanchardstown, Dublin 15, and Shannon, County Clare. Bristol Myers Squibb describes Cruiserath as a multi-product cell-culture biologics manufacturing facility within its global Product Development and Supply organisation. The external manufacturing network manages drug-manufacturing work performed by third parties. The supplied sources do not date the opening of these facilities, so no construction or launch years are assigned here. The present Irish organisation also includes commercial functions and offers career opportunities across multiple functions. Bristol Myers Squibb reports that it employs approximately 1,000 people in Ireland. Its Irish contact information identifies Cruiserath and the Blanchardstown corporate park in Dublin 15, and lists Shannon as an external-manufacturing location. The available sources do not provide a single formal headquarters designation for the Irish operation. Alongside its operating footprint, the Irish website sets out a grants, giving and corporate sponsorship process. It describes possible support for non-profit organisations working in healthcare-related support, medical and scientific education, research, and community charitable activities. The stated forms of support include charitable donations, in-kind assistance, independent medical education, scholarships, fellowships, patient education grants, sponsorship and umbrella research grants. The company says requests are considered under its business-conduct and ethics criteria and relevant Irish pharmaceutical and regulatory requirements. The evidence presents Bristol Myers Squibb (Ireland) as part of the global Bristol Myers Squibb company, rather than as an independently profiled pharmaceutical brand. It does not establish a local founder, local executive roster, separate Irish stock listing, or named Irish medicine portfolio. The latest dated preparation note in the supplied Ireland-site material is November 2025; the homepage snippet also carries an August 2026 preparation date.

• 1964

  Bristol Myers Squibb begins operations in Ireland

• Cruiserath biologics facility forms part of the Irish footprint

• External manufacturing operations identified in Dublin and Shannon

The Irish operation combines biopharmaceutical manufacturing and external-manufacturing activities with commercial functions as part of Bristol Myers Squibb’s global network.

• Innovative medicines

  The Irish site describes the parent company as discovering, developing and delivering medicines for serious diseases; it does not name Irish product brands in the supplied evidence.

• Active pharmaceutical ingredients

  The company identifies its initial Irish operation as an active pharmaceutical ingredient plant in Swords.

• Biologics drug substances

  Cruiserath is described as a multi-product cell-culture biologics manufacturing facility.

1. 1Bristol Myers Squibb - Global Biopharmaceutical Companybms.com
2. 2Grants, Giving & Corporate Sponsorship Support - Bristol Myers Squibbbms.com
3. 3About Us - Bristol Myers Squibbbms.com
4. 4Contact Us - Bristol Myers Squibbbms.com
5. 5Bristol-Myers Squibb (Ireland)wikidata.org